CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
-8.4%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.07B
AUM Growth
+$4.07B
(-15%)
Cap. Flow
-$257M
Cap. Flow
% of AUM
-6.3%
Top 10 Holdings %
Top 10 Hldgs %
18.03%
Holding
681
New
46
Increased
263
Reduced
259
Closed
64
Top Buys
| 1 |
Nike
NKE
|
$34.7M |
| 2 |
Starbucks
SBUX
|
$27.3M |
| 3 |
Procter & Gamble
PG
|
$26M |
| 4 |
McKesson
MCK
|
$24M |
| 5 |
NVIDIA
NVDA
|
$23.9M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$109M |
| 2 |
iShares US Real Estate ETF
IYR
|
$30.4M |
| 3 |
EMC
EMC CORPORATION
EMC
|
$23.6M |
| 4 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
$20.3M |
| 5 |
Kellanova
K
|
$20.3M |
Sector Composition
| 1 | Healthcare | 28.72% |
| 2 | Financials | 13.85% |
| 3 | Technology | 10.07% |
| 4 | Consumer Discretionary | 8.55% |
| 5 | Consumer Staples | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $114M | 2.8% | 1,161,790 +82,817 | +8% | +$8.13M |
|
2
Amgen
AMGN
$155B
| $107M | 2.64% | 776,974 -94,675 | -11% | -$13.1M |
|
3
Johnson & Johnson
JNJ
$427B
| $96M | 2.36% | 1,028,471 +47,086 | +5% | +$4.4M |
|
4
Apple
AAPL
$3.45T
| $71.8M | 1.76% | 650,667 -50,030 | -7% | -$5.52M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $70.2M | 1.72% | 648,730 +41,548 | +7% | +$4.49M |
|
6
PepsiCo
PEP
$204B
| $62.6M | 1.54% | 663,607 +215,465 | +48% | +$20.3M |
|
7
Biogen
BIIB
$19.4B
| $62.1M | 1.52% | 212,736 +9,530 | +5% | +$2.78M |
|
|
8
Nike
NKE
$114B
| $53.4M | 1.31% | 434,494 +282,050 | +185% | +$34.7M |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $50.2M | 1.23% | 107,868 -14,485 | -12% | -$6.74M |
|
|
10
Starbucks
SBUX
$100B
| $46.6M | 1.14% | 819,862 +481,108 | +142% | +$27.3M |
|
11
Visa
V
$683B
| $45M | 1.1% | 645,279 -41,197 | -6% | -$2.87M |
|
12
Pfizer
PFE
$141B
| $44.7M | 1.1% | 1,422,970 -81,943 | -5% | -$2.57M |
|
|
13
Procter & Gamble
PG
$368B
| $44.2M | 1.09% | 614,496 +361,187 | +143% | +$26M |
|
14
Exxon Mobil
XOM
$487B
| $40.3M | 0.99% | 541,596 -70,836 | -12% | -$5.27M |
|
15
AT&T
T
$209B
| $36.1M | 0.89% | 1,108,384 +78,386 | +8% | +$2.55M |
|
16
Merck
MRK
$210B
| $35.4M | 0.87% | 716,892 -79,505 | -10% | -$3.93M |
|
17
Qualcomm
QCOM
$173B
| $34.5M | 0.85% | 641,779 -339,254 | -35% | -$18.2M |
|
18
Verizon
VZ
$186B
| $34M | 0.84% | 781,605 -90,508 | -10% | -$3.94M |
|
19
Incyte
INCY
$16.5B
| $32.8M | 0.81% | 297,384 +34,212 | +13% | +$3.77M |
|
20
Microsoft
MSFT
$3.77T
| $31M | 0.76% | 699,657 -308,612 | -31% | -$13.7M |
|
21
AbbVie
ABBV
$372B
| $30.7M | 0.75% | 563,563 +27,428 | +5% | +$1.49M |
|
22
Coca-Cola
KO
$297B
| $30.5M | 0.75% | 761,286 -38,390 | -5% | -$1.54M |
|
|
23
McKesson
MCK
$85.4B
| $27.7M | 0.68% | 149,655 +129,737 | +651% | +$24M |
|
24
Travelers Companies
TRV
$61.1B
| $27.6M | 0.68% | 276,986 -24,302 | -8% | -$2.42M |
|
25
Vertex Pharmaceuticals
VRTX
$100B
| $27.4M | 0.67% | 262,845 -1,009 | -0.4% | -$105K |
|